PARNAXLAB

Parnax Lab Ltd.

BSE: 506128

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

142.70-1.3 (-0.90%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

22.9 / 100

Value Score

84.5 / 100

Price Momentum Score

75.9 / 100

QVM Score

70.3 / 100

Key Metrics

Market Cap

163.90

P/E (TTM)

13.92

P/B

1.72

P/S (TTM)

0.66

EV/EBITDA

8.97

CAPE (5Y)

15.47

ROE (TTM)

13.22

ROCE (TTM)

11.61

ROA (TTM)

5.64

Avg 3Y ROE

14.16

Earnings 3Y CAGR

9.67

Sales 3Y CAGR

14.03

Sales 5Y CAGR

22.51

Debt/Equity

0.87

Consensus TP

Strong Buy %

Promoter Holding

72.30

Pledged %

9.41

Stock Analysis

Fundamental analysis overview of Parnax Lab Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 13.92 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -55.14%

What is P/E Ratio?

Median: 31.03

Value 13.92

-215.443203.67

Strong price momentum

Price Momentum score of 75.9 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

75.9 / 100

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 32.39% for 12-month ended 31 Mar 2026 and the growth was 21.15 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 32.39

-82.35114662

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.87 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.03 in the last 1 year

What is Debt to Equity?

Negative

Moderate ROE but declining trend

The company reported moderate ROE of 13.22% for 12-month ended 31 Mar 2026 but ROE declined by -166 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of 7.73% for 12-month ended 31 Mar 2026 and operating margin declined by -259 bps from 1 year ago

What is Operating profit margin?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of 2.4% for 12-month ended 31 Mar 2026 and the growth was 5.72 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 41.5 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

41.5 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Parnax Lab Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Parnax Lab Ltd. Shareholding Pattern

Quarterly breakdown of Parnax Lab Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	62.59	62.59	62.59	62.59	62.59	62.59	62.59	62.59	67.58	67.58	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30
Indian Promoter	62.59	62.59	62.59	62.59	62.59	62.59	62.59	62.59	67.58	67.58	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30	72.30
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	37.41	37.41	37.41	37.41	37.41	37.41	37.41	37.41	32.42	32.42	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70	27.70
Bodies Corporate	1.95	1.78	1.75	1.38	1.04	0.79	0.80	0.70	0.33	0.54	0.50	0.59	0.60	0.40	0.36	0.78	0.55	0.59	0.60	0.30	0.31	0.31	0.50	1.12	1.99
Others (incl. Retail) No. of shareholders	35.46 2,268	35.63 2,225	35.66 2,166	36.03 2,158	36.37 2,072	36.62 2,175	36.61 2,107	36.71 2,229	32.09 2,379	31.88 2,580	27.20 3,070	27.11 3,044	27.10 3,033	27.30 3,190	27.34 3,511	26.92 3,499	27.15 4,461	27.11 4,371	27.10 4,136	27.40 4,487	27.39 4,409	27.39 4,287	27.20 4,085	26.58 3,870	25.71 3,693

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Parnax Lab Ltd. is not part of any tracked index.

Prominent Investor Holdings

Dheeraj Kumar Lohia and Associates

Dec 2021

1.80%

₹ 2 Cr

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Parnax Lab Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Ami Mihir Shah Promoter & Director	July-2022	Conversion of security (Acquisition) 5th Jul 2022	5.80 %	₹ 43.50	2.64 lac	₹ 1.15 cr
Baiju Mahasukhlal Shah Promoter & Director	July-2022	Conversion of security (Acquisition) 5th Jul 2022	9.07 %	₹ 43.50	4.39 lac	₹ 1.91 cr
Ila Baiju Shah Promoter Group	July-2022	Conversion of security (Acquisition) 5th Jul 2022	9.40 %	₹ 43.50	4.39 lac	₹ 1.91 cr
Pragna Prakash Shah Promoter Group	July-2022	Conversion of security (Acquisition) 5th Jul 2022	8.17 %	₹ 43.50	2.64 lac	₹ 1.15 cr
Prakash Mansukhlal Shah Promoter & Director	July-2022	Conversion of security (Acquisition) 5th Jul 2022	9.55 %	₹ 43.50	2.64 lac	₹ 1.15 cr
Ami Mihir Shah Promoter & Director	March-2022	Conversion of security (Acquisition) 31st Mar 2022	3.14 %	₹ 43.50	2.62 lac	₹ 1.14 cr
Baiju Mahasukhlal Shah Promoter & Director	March-2022	Conversion of security (Acquisition) 31st Mar 2022	6.40 %	₹ 43.50	2.62 lac	₹ 1.14 cr
Ila Baiju Shah Promoter Group	March-2022	Conversion of security (Acquisition) 31st Mar 2022	6.73 %	₹ 43.50	2.62 lac	₹ 1.14 cr
Pragna Prakash Shah Promoter Group	March-2022	Conversion of security (Acquisition) 31st Mar 2022	5.50 %	₹ 43.50	2.62 lac	₹ 1.14 cr
Prakash Mansukhlal Shah Promoter & Director	March-2022	Conversion of security (Acquisition) 31st Mar 2022	6.88 %	₹ 43.50	2.62 lac	₹ 1.14 cr

No corporate action data available.

Company Profile

Overview of Parnax Lab Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing ...

Key personnel

Mr. Prakash Mihir Shah

Managing Director Cum Chief Executive Officer

Mrs. Preet Vijay Kukreja

Compliance Officer, Company Secretary

Mr. Binoy Baiju ShahD

Executive Director Cum Chief Financial Officer

Mrs. Ami Mihir ShahD

Women Non-Executive Director

Mr. Vijay Kumar AyareD

Additional Non-Executive Independent Director

Mr. Harish S PanpaliaD

Non-Executive Independent Director

Mr. Yogesh VariaD

Non-Executive Independent Director

Mr. Yogesh VariaD

Additional Non-Executive Independent Director

Incorporated on

03 Aug 1982

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

15 Sep 2009

Free Float

29,95,850

Website

https://naxparlab.com/

Phone no.

+912230015666

Address

Bldg, 104 - 107 Jogani Industrial Cplx, Road No 8, MUMBAI, 400022, India

Frequently Asked Questions

What is the current share price of Parnax Lab Ltd.?

The current share price of Parnax Lab Ltd. is ₹ 142.70 as of 10 Jul 2026.

What is the market capitalisation of Parnax Lab Ltd.?

The market capitalisation of Parnax Lab Ltd. stands at ₹ 163.90 Cr.

What is the PE ratio of Parnax Lab Ltd.?

The Price-to-Earnings (PE) ratio of Parnax Lab Ltd. is 13.92 as of the latest trailing twelve months data.

What is the ROE and ROCE of Parnax Lab Ltd.?

Parnax Lab Ltd. has a Return on Equity (ROE) of 13.22% and a Return on Capital Employed (ROCE) of 11.61% as per the latest financial reports.

What is the 52-week high and low of Parnax Lab Ltd.?

The 52-week high of Parnax Lab Ltd. is - and the 52-week low is -.

What is the dividend yield of Parnax Lab Ltd.?

The dividend yield of Parnax Lab Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Parnax Lab Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 25.71% of Parnax Lab Ltd. shares.

What sector does Parnax Lab Ltd. belong to?

Parnax Lab Ltd. operates in the Healthcare sector.

What is the beta of Parnax Lab Ltd.?

The beta of Parnax Lab Ltd. is 1.23, indicating its price volatility relative to the broader market. Over the past 1 year, Parnax Lab Ltd. has delivered an absolute return of 37.21%.

What is the RSI of Parnax Lab Ltd.?

The 14-day Relative Strength Index (RSI) of Parnax Lab Ltd. is 53.42, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Parnax Lab Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Parnax Lab Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile